Matches in SemOpenAlex for { <https://semopenalex.org/work/W1505774641> ?p ?o ?g. }
- W1505774641 endingPage "72" @default.
- W1505774641 startingPage "66" @default.
- W1505774641 abstract "Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regulatory, Quality, Manufacturing Postmarketing Phase IV Treatment of refractory gout remains a challenge on drug development. While pegloticase, a recombinant mammalian uricase modified with monomethoxyl poly(ethylene glycol) (mPEG) is effective in treating refractory gout, after continued treatment for 3 months biweekly at a therapeutic dose of 0.14 mg/kg body weight, it elicits an immune response against mPEG in nearly 20% of patients. For continued treatment of refractory gout, PEGylated uricases at monthly therapeutic doses below 4 μg/kg body weight have promise. To formulate uricases to achieve monthly therapeutic regimens requires pharmacodynamics simulation and experimentation including molecular engineering of uricases based on rational design and evolution biotechnology in combination to improve their inherent catalytic efficiency, thermostability and selectivity for urate over xanthine and optimization of the number and distribution of accessible reactive amino acid residues in native uricases for site-specific PEGylation with poly(ethylene glycol) derivatives with lower of immunogenicity than mPEG to retain activity, minimize immunogenicity and enhance the pharmacokinetics of the PEGylated uricase. These issues are briefly reviewed as a means to stimulate the development of safer uricase formulations for continued treatment of refractory gout." @default.
- W1505774641 created "2016-06-24" @default.
- W1505774641 creator A5036566273 @default.
- W1505774641 creator A5037378495 @default.
- W1505774641 creator A5038268415 @default.
- W1505774641 creator A5082028797 @default.
- W1505774641 date "2012-03-01" @default.
- W1505774641 modified "2023-10-16" @default.
- W1505774641 title "Uricases as Therapeutic Agents to Treat Refractory Gout: Current States and Future Directions" @default.
- W1505774641 cites W110928060 @default.
- W1505774641 cites W1516150813 @default.
- W1505774641 cites W1918944513 @default.
- W1505774641 cites W1968008584 @default.
- W1505774641 cites W1968290904 @default.
- W1505774641 cites W1972576513 @default.
- W1505774641 cites W1974224389 @default.
- W1505774641 cites W1974526584 @default.
- W1505774641 cites W1975649173 @default.
- W1505774641 cites W1976585433 @default.
- W1505774641 cites W1978731039 @default.
- W1505774641 cites W1982161794 @default.
- W1505774641 cites W1987065191 @default.
- W1505774641 cites W1989067119 @default.
- W1505774641 cites W1989895765 @default.
- W1505774641 cites W1993575761 @default.
- W1505774641 cites W2002674574 @default.
- W1505774641 cites W2005495542 @default.
- W1505774641 cites W2011367781 @default.
- W1505774641 cites W2011891975 @default.
- W1505774641 cites W2012019710 @default.
- W1505774641 cites W2012443018 @default.
- W1505774641 cites W2014015529 @default.
- W1505774641 cites W2015336570 @default.
- W1505774641 cites W2015543435 @default.
- W1505774641 cites W2019183242 @default.
- W1505774641 cites W2021110479 @default.
- W1505774641 cites W2027026258 @default.
- W1505774641 cites W2034451231 @default.
- W1505774641 cites W2036598926 @default.
- W1505774641 cites W2037708403 @default.
- W1505774641 cites W2038510181 @default.
- W1505774641 cites W2046983748 @default.
- W1505774641 cites W2050000571 @default.
- W1505774641 cites W2059087939 @default.
- W1505774641 cites W2061799292 @default.
- W1505774641 cites W2070950350 @default.
- W1505774641 cites W2076472674 @default.
- W1505774641 cites W2082169221 @default.
- W1505774641 cites W2082429489 @default.
- W1505774641 cites W2082821238 @default.
- W1505774641 cites W2086409978 @default.
- W1505774641 cites W2089623801 @default.
- W1505774641 cites W2096648003 @default.
- W1505774641 cites W2108056398 @default.
- W1505774641 cites W2111237091 @default.
- W1505774641 cites W2115443699 @default.
- W1505774641 cites W2132895884 @default.
- W1505774641 cites W2139708400 @default.
- W1505774641 cites W2142010926 @default.
- W1505774641 cites W2145786098 @default.
- W1505774641 cites W2146447716 @default.
- W1505774641 cites W2154180317 @default.
- W1505774641 cites W2156097130 @default.
- W1505774641 cites W2157334869 @default.
- W1505774641 cites W2157888633 @default.
- W1505774641 cites W2167557712 @default.
- W1505774641 cites W2168630256 @default.
- W1505774641 cites W4206568668 @default.
- W1505774641 cites W4211198032 @default.
- W1505774641 cites W4231766912 @default.
- W1505774641 cites W4237101852 @default.
- W1505774641 cites W4252751859 @default.
- W1505774641 cites W44356197 @default.
- W1505774641 doi "https://doi.org/10.1002/ddr.20493" @default.
- W1505774641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3365602" @default.
- W1505774641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22665944" @default.
- W1505774641 hasPublicationYear "2012" @default.
- W1505774641 type Work @default.
- W1505774641 sameAs 1505774641 @default.
- W1505774641 citedByCount "55" @default.
- W1505774641 countsByYear W15057746412012 @default.
- W1505774641 countsByYear W15057746412013 @default.
- W1505774641 countsByYear W15057746412014 @default.
- W1505774641 countsByYear W15057746412015 @default.
- W1505774641 countsByYear W15057746412016 @default.
- W1505774641 countsByYear W15057746412017 @default.
- W1505774641 countsByYear W15057746412018 @default.
- W1505774641 countsByYear W15057746412019 @default.
- W1505774641 countsByYear W15057746412020 @default.
- W1505774641 countsByYear W15057746412021 @default.
- W1505774641 countsByYear W15057746412022 @default.
- W1505774641 countsByYear W15057746412023 @default.
- W1505774641 crossrefType "journal-article" @default.
- W1505774641 hasAuthorship W1505774641A5036566273 @default.
- W1505774641 hasAuthorship W1505774641A5037378495 @default.
- W1505774641 hasAuthorship W1505774641A5038268415 @default.
- W1505774641 hasAuthorship W1505774641A5082028797 @default.
- W1505774641 hasBestOaLocation W15057746412 @default.